Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENZALUTAMIDE vs EPCORITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENZALUTAMIDE vs EPCORITAMAB: Safety Overview

Metric ENZALUTAMIDE EPCORITAMAB
Total FAERS Reports 49,270 2,041
Deaths Reported 9,676 430
Death Rate 19.6% 21.1%
Hospitalizations 9,282 1,652
Average Patient Age 76.0 yrs 67.5 yrs
% Female Patients 0.6% 47.5%
FDA Approval Date Apr 22, 2022 N/A
Manufacturer Astellas Pharma US, Inc. Genmab US, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A